NDC25021-0672-10 — ATRACURIUM BESYLATE INJECTION

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC25021-0672-10: ATRACURIUM BESYLATE INJECTION.

The ATRACURIUM BESYLATE INJECTION is a the manufacturer industrial component. Key specifications include special_features: MULTIDOSE VIALS, primary_container_type: VIAL, protective_storage_feature: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS, total_primary_container_quantity: 10, primary_container_content_quantity: 10.000 MILLILITERS, active_medicament_medicinal_strength: 10.000 MILLIGRAMS ATRACURIUM BESYLATE PER MILLILITER. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-215-7755, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC25021-0672-10

NSN: 6505-01-215-7755
FSC: 6505 — Drugs and Biologicals
CAGE: 4RP13 — SAGENT PHARMACEUTICALS, INC DBA SAGENT PHARMACEUTICALS, INC (USA)

SPECIFICATIONS

special_features	MULTIDOSE VIALS
primary_container_type	VIAL
protective_storage_feature	REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
total_primary_container_quantity	10
primary_container_content_quantity	10.000 MILLILITERS
active_medicament_medicinal_strength	10.000 MILLIGRAMS ATRACURIUM BESYLATE PER MILLILITER
part_name_assigned_by_controlling_agency	ATRACURIUM BESYLATE INJECTION 10MG/ML 10ML VIAL 10S
NSN	6505-01-215-7755

COMPONENT DIAGRAM

KEY FEATURES

•

PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS

•

PRIMARY CONTAINER TYPE: VIAL

•

PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS ATRACURIUM BESYLATE PER MILLILITER

•

TOTAL PRIMARY CONTAINER QUANTITY: 10

TECHNICAL CHARACTERISTICS

PRIMARY CONTAINER CONTENT QUANTITY	10.000 MILLILITERS
PRIMARY CONTAINER TYPE	VIAL
SPECIAL FEATURES	MULTIDOSE VIALS
PROTECTIVE STORAGE FEATURE	REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PART NAME ASSIGNED BY CONTROLLING AGENCY	ATRACURIUM BESYLATE INJECTION 10MG/ML 10ML VIAL 10S
ACTIVE MEDICAMENT MEDICINAL STRENGTH	10.000 MILLIGRAMS ATRACURIUM BESYLATE PER MILLILITER
TOTAL PRIMARY CONTAINER QUANTITY	10

OTHER ITEMS IN FSC 6505 — Drugs and Biologicals

Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.

6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347

SUBSTITUTES & CROSS-REFERENCES 1

NDC00409-1105-02Reference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedNo demilitarization required

Ready to buy NDC25021-0672-10?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC25021-0672-10?

NDC25021-0672-10 is a ATRACURIUM BESYLATE INJECTION.

What parts can replace NDC25021-0672-10?

There is 1 known substitute for NDC25021-0672-10: NDC00409-1105-02. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC25021-0672-10?

NDC25021-0672-10 is cataloged in the U.S. Government catalog under NSN 6505-01-215-7755. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC25021-0672-10 — ATRACURIUM BESYLATE INJECTION

Request a Quote — NDC25021-0672-10